Port Hueneme biotech company Stellar Biotechnologies announced a steep drop in revenues for its first fiscal quarter 2018 and a net loss of $1.4 million. Revenues fell from $140,000 in the first quarter of last year to $20,000 for the most recent quarter, ended Dec. 31, on a decline in sales volumes as customers move…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
